Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Jong‐Seon Park, Mahn‐Won Park et al.|The Lancet|2021Cited by 202
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Joo-Yong Hahn, Yong Hwan Park et al.|The Lancet|2025Cited by 86
Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents - The DATE (Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent) Registry -Joo‐Yong Hahn, The DATE Registry Investigators, Young Bin Song et al.|Circulation Journal|2010Cited by 26
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Young Bin Song, Joo‐Yong Hahn et al.|Cardiology Journal|2021Cited by 23
Current Practice of Transradial Coronary Angiography and Intervention: Results from the Korean Transradial Intervention Prospective RegistryYoung Jin Youn, Sang‐Wook Kim, Jun‐Won Lee et al.|Korean Circulation Journal|2015Cited by 10